166 related articles for article (PubMed ID: 1332602)
1. Anti-human immunodeficiency virus (HIV) agents are also potent and selective inhibitors of feline immunodeficiency virus (FIV)-induced cytopathic effect: development of a new method for screening of anti-FIV substances in vitro.
Tanabe-Tochikura A; Tochikura TS; Blakeslee JR; Olsen RG; Mathes LE
Antiviral Res; 1992 Aug; 19(2):161-72. PubMed ID: 1332602
[TBL] [Abstract][Full Text] [Related]
2. C-Terminal gp40 peptide analogs inhibit feline immunodeficiency virus: cell fusion and virus spread.
Medinas RJ; Lambert DM; Tompkins WA
J Virol; 2002 Sep; 76(18):9079-86. PubMed ID: 12186891
[TBL] [Abstract][Full Text] [Related]
3. Bicyclams, selective antagonists of the human chemokine receptor CXCR4, potently inhibit feline immunodeficiency virus replication.
Egberink HF; De Clercq E; Van Vliet AL; Balzarini J; Bridger GJ; Henson G; Horzinek MC; Schols D
J Virol; 1999 Aug; 73(8):6346-52. PubMed ID: 10400726
[TBL] [Abstract][Full Text] [Related]
4. The mutation frequency of feline immunodeficiency virus enhanced by 3'-azido-3'-deoxythymidine.
LaCasse RA; Remington KM; North TW
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 May; 12(1):26-32. PubMed ID: 8624757
[TBL] [Abstract][Full Text] [Related]
5. Derivatives of 4-amino-3,6-disulfonato-1,8-naphthalimide inhibit reverse transcriptase and suppress human and feline immunodeficiency virus expression in cultured cells.
Rideout D; Schinazi R; Pauza CD; Lovelace K; Chiang LC; Calogeropoulou T; McCarthy M; Elder JH
J Cell Biochem; 1993 Apr; 51(4):446-57. PubMed ID: 7684385
[TBL] [Abstract][Full Text] [Related]
6. Human immunodeficiency virus integrase inhibitors efficiently suppress feline immunodeficiency virus replication in vitro and provide a rationale to redesign antiretroviral treatment for feline AIDS.
Savarino A; Pistello M; D'Ostilio D; Zabogli E; Taglia F; Mancini F; Ferro S; Matteucci D; De Luca L; Barreca ML; Ciervo A; Chimirri A; Ciccozzi M; Bendinelli M
Retrovirology; 2007 Oct; 4():79. PubMed ID: 17971219
[TBL] [Abstract][Full Text] [Related]
7. Feline immunodeficiency virus lacks sensitivity to the antiviral activity of feline IFN-gamma.
Tanabe T; Yamamoto JK
J Interferon Cytokine Res; 2001 Dec; 21(12):1039-46. PubMed ID: 11798461
[TBL] [Abstract][Full Text] [Related]
8. Neurologic disease in feline immunodeficiency virus infection: disease mechanisms and therapeutic interventions for NeuroAIDS.
Power C
J Neurovirol; 2018 Apr; 24(2):220-228. PubMed ID: 29247305
[TBL] [Abstract][Full Text] [Related]
9. Antiviral activity in vitro of Urtica dioica L., Parietaria diffusa M. et K. and Sambucus nigra L.
Uncini Manganelli RE; Zaccaro L; Tomei PE
J Ethnopharmacol; 2005 Apr; 98(3):323-7. PubMed ID: 15814267
[TBL] [Abstract][Full Text] [Related]
10. Combined effect of zidovudine (ZDV), lamivudine (3TC) and abacavir (ABC) antiretroviral therapy in suppressing in vitro FIV replication.
Bisset LR; Lutz H; Böni J; Hofmann-Lehmann R; Lüthy R; Schüpbach J
Antiviral Res; 2002 Jan; 53(1):35-45. PubMed ID: 11684314
[TBL] [Abstract][Full Text] [Related]
11. Antiretroviral spermicide WHI-07 prevents vaginal and rectal transmission of feline immunodeficiency virus in domestic cats.
D'Cruz OJ; Waurzyniak B; Uckun FM
Antimicrob Agents Chemother; 2004 Apr; 48(4):1082-8. PubMed ID: 15047505
[TBL] [Abstract][Full Text] [Related]
12. Reduced provirus burden and enhanced humoral immune function in AZT-treated SCID-feline mice inoculated with feline immunodeficiency virus.
Johnson CM; Selleseth DW; Ellis MN; Childers TA; Tompkins MB; Tompkins WA
Vet Immunol Immunopathol; 1995 May; 46(1-2):169-80. PubMed ID: 7618256
[TBL] [Abstract][Full Text] [Related]
13. Fusion activity dissociated from replication ability in feline immunodeficiency virus (FIV) in human cells.
Tochikura TS; Tanabe-Tochikura A; Hayes KA; Lazo A; Bailer RT; Blakeslee JR; Lafrado LJ; Roy-Burman P; Pandey R; Olsen RG
J Acquir Immune Defic Syndr (1988); 1993 Dec; 6(12):1301-10. PubMed ID: 8254466
[TBL] [Abstract][Full Text] [Related]
14. 8-Difluoromethoxy-4-quinolone derivatives as anti-feline immunodeficiency virus (FIV) agents: important structural features for inhibitory activity of FIV replication.
Kashiwase H; Katsube T; Kimura T; Nishigaki T; Yamashita M
J Vet Med Sci; 2000 May; 62(5):499-504. PubMed ID: 10852398
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological inhibition of feline immunodeficiency virus (FIV).
Mohammadi H; Bienzle D
Viruses; 2012 May; 4(5):708-24. PubMed ID: 22754645
[TBL] [Abstract][Full Text] [Related]
16. Mutants of feline immunodeficiency virus resistant to 3'-azido-3'-deoxythymidine.
Remington KM; Chesebro B; Wehrly K; Pedersen NC; North TW
J Virol; 1991 Jan; 65(1):308-12. PubMed ID: 1845891
[TBL] [Abstract][Full Text] [Related]
17. Antiviral efficacy of nine nucleoside reverse transcriptase inhibitors against feline immunodeficiency virus in feline peripheral blood mononuclear cells.
Schwartz AM; McCrackin MA; Schinazi RF; Hill PB; Vahlenkamp TW; Tompkins MB; Hartmann K
Am J Vet Res; 2014 Mar; 75(3):273-81. PubMed ID: 24564313
[TBL] [Abstract][Full Text] [Related]
18. Potent anti-feline immunodeficiency virus and anti-human immunodeficiency virus effect of IFN-tau.
Pontzer CH; Yamamoto JK; Bazer FW; Ott TL; Johnson HM
J Immunol; 1997 May; 158(9):4351-7. PubMed ID: 9126998
[TBL] [Abstract][Full Text] [Related]
19. Multiple-drug-resistant mutants of feline immunodeficiency virus selected with 2',3'-dideoxyinosine alone and in combination with 3'-azido-3'-deoxythymidine.
Gobert JM; Remington KM; Zhu YQ; North TW
Antimicrob Agents Chemother; 1994 Apr; 38(4):861-4. PubMed ID: 8031060
[TBL] [Abstract][Full Text] [Related]
20. Effects of feline immunodeficiency virus on feline monocyte-derived dendritic cells infected by spinoculation.
Freer G; Matteucci D; Mazzetti P; Tarabella F; Catalucci V; Bendinelli M
J Gen Virol; 2007 Sep; 88(Pt 9):2574-2582. PubMed ID: 17698669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
